HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sidong Huang Selected Research

Estrogen Receptors

11/2019eIF4A Inhibitors Suppress Cell-Cycle Feedback Response and Acquired Resistance to CDK4/6 Inhibition in Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sidong Huang Research Topics

Disease

19Neoplasms (Cancer)
01/2022 - 04/2009
4Breast Neoplasms (Breast Cancer)
01/2022 - 05/2018
4Colonic Neoplasms (Colon Cancer)
04/2014 - 01/2012
3Melanoma (Melanoma, Malignant)
11/2017 - 01/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 01/2019
2Retinoblastoma (Glioblastoma, Retinal)
01/2019 - 10/2014
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2016 - 08/2015
2Neuroblastoma
07/2010 - 04/2009
1Triple Negative Breast Neoplasms
01/2022
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2020
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Hypersensitivity (Allergy)
01/2019
1Small Cell Carcinoma
01/2019
1Kidney Neoplasms (Kidney Cancer)
05/2018
1Renal Cell Carcinoma (Grawitz Tumor)
05/2018
1Carcinogenesis
11/2017
1Chronic Pancreatitis
12/2016
1Neoplasm Metastasis (Metastasis)
12/2016
1Adenocarcinoma
08/2015
1Stomach Neoplasms (Stomach Cancer)
04/2014
1Neurofibromatosis 1 (Neurofibromatosis Type I)
11/2013
1Inborn Genetic Diseases (Disease, Hereditary)
11/2013
1Lung Neoplasms (Lung Cancer)
11/2012

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2013
5Pharmaceutical PreparationsIBA
01/2021 - 01/2012
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
04/2014 - 07/2010
4Cyclin D1IBA
01/2020 - 01/2019
3ChromatinIBA
01/2019 - 04/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 08/2015
2Small Interfering RNA (siRNA)IBA
01/2020 - 04/2014
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2017 - 04/2014
2Phosphotransferases (Kinase)IBA
04/2014 - 11/2012
2ErbB Receptors (EGF Receptor)IBA
04/2014 - 11/2012
2Gefitinib (Iressa)FDA Link
11/2012 - 01/2012
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010 - 04/2009
1glembatumumab vedotinIBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Buthionine SulfoximineIBA
01/2021
1Phenformin (Fenformin)IBA
01/2021
1AnthracyclinesIBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1CalciumIBA
01/2021
1BiguanidesIBA
01/2021
1Glutathione (Reduced Glutathione)IBA
01/2021
1Epirubicin (Ellence)FDA LinkGeneric
01/2021
1Histone Deacetylase InhibitorsIBA
01/2021
1adhesion receptorIBA
01/2020
1LigandsIBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1CyclinsIBA
11/2019
1Estrogen ReceptorsIBA
11/2019
1Eukaryotic Initiation Factor-4A (Eukaryotic Initiation Factor 4A)IBA
11/2019
1palbociclibIBA
11/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018
1src-Family KinasesIBA
05/2018
1Syk KinaseIBA
05/2018
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2018
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
11/2017
1Haloperidol (Haldol)FDA LinkGeneric
12/2016
1Pimozide (Orap)FDA Link
12/2016
1talazoparibIBA
08/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
08/2015
1DNA (Deoxyribonucleic Acid)IBA
08/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
08/2015
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2014
1Proto-Oncogene Proteins c-metIBA
04/2014
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2014
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
04/2014
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
04/2014
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
04/2014
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
11/2013
1Mediator ComplexIBA
11/2012
1Tyrosine (L-Tyrosine)FDA Link
11/2012
1Oncogene Proteins (Oncogene Protein)IBA
01/2012
1Cetuximab (Erbitux)FDA Link
01/2012
1Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2012
1VemurafenibIBA
01/2012
1RetinoidsIBA
04/2009

Therapy/Procedure

4Therapeutics
01/2021 - 01/2012
3Drug Therapy (Chemotherapy)
01/2021 - 11/2012
1Investigational Therapies (Experimental Therapy)
01/2022